Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Hearing Loss 2Deafness 2

Interventions

Cyclophosphamide 910Carboplatin 788pembrolizumab 747Paclitaxel 744Bevacizumab 716Cisplatin 709Gemcitabine 621Docetaxel 584Rituximab 558Radiotherapy 548Dexamethasone 511Nivolumab 491Doxorubicin 445Fluorouracil 392Capecitabine 382Etoposide 358Pemetrexed 339Cytarabine 335Oxaliplatin 335Lenalidomide 328Prednisone 327Erlotinib Hydrochloride 323fludarabine phosphate 316Trastuzumab 305Leucovorin 299fludarabine 296Vincristine 288Bortezomib 284Filgrastim 284Cetuximab 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Ankle Brachial Index × Clear all
NCT01864291 2020-06-02

ABI

Massachusetts Eye and Ear Infirmary

Phase NA Terminated
9 enrolled 10 charts

Deafness, Hearing Loss

NCT01736267 2020-05-06

Auditory Brainstem Implant (ABI) in Adult Non-Neurofibromatosis Type 2 Subjects

Massachusetts Eye and Ear Infirmary

Phase NA Terminated
3 enrolled 8 charts

Deafness, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡